{"id":"W2808209724","doi":"10.1136/annrheumdis-2018-eular.2140","title":"OP0307 Efficacy and safety of risankizumab, a selective il-23p19 inhibitor, in patients with active psoriatic arthritis over 24 weeks: results from a phase 2 trial","year":2018,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":53,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriatic arthritis; Dactylitis; Enthesitis; Internal medicine; Placebo; Clinical endpoint; Golimumab; Synovitis; Gastroenterology; Arthritis; Surgery; Rheumatoid arthritis; Randomized controlled trial; Etanercept; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001449835,0.0002366478,0.0005983029,0.0001091086,0.0001173508,0.000009457173,0.0001852595,0.0001200825,0.00008820124],"category_scores_gemma":[0.0006704841,0.0001557682,0.0001254815,0.000251425,0.0004118835,0.0001428922,0.00008612958,0.00009135537,0.00001171813],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002152428,"about_ca_system_score_gemma":0.0001293717,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004709141,"about_ca_topic_score_gemma":0.0001160637,"domain_scores_codex":[0.9982568,0.0004521228,0.000600257,0.0003215651,0.0001116545,0.0002575858],"domain_scores_gemma":[0.9981105,0.0007795356,0.0005386167,0.0003837279,0.0001474975,0.00004016788],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.4502345,0.007172259,0.004631778,0.00004738391,0.002555471,0.000002012237,0.005435374,0.000003047489,0.0002130032,0.00005367267,0.002610442,0.527041],"study_design_scores_gemma":[0.3065177,0.005897528,0.6625402,0.001811497,0.0005778546,9.728773e-7,0.0003162444,0.0000062921,0.02081509,0.0009669142,0.0002212985,0.0003284033],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9929907,0.001291565,0.000002235408,0.00007280955,0.0004333377,0.001021845,0.004078629,0.00001566789,0.00009326303],"genre_scores_gemma":[0.999142,0.0004156678,0.00002160834,0.00003042647,0.00003613466,0.0000378565,0.0002576188,0.00001572139,0.00004300036],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6579084,"threshold_uncertainty_score":0.6352044,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01758291275985717,"score_gpt":0.26635962034093,"score_spread":0.2487767075810728,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}